Thursday, December 14, 2017
 
 
Company News: Page (1) of 1 - 09/08/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Amgen Highlights The Latest EVENITY™ (Romosozumab) And Prolia® (Denosumab) Research At The American Society For Bone And Mineral Research Annual Meeting
First Presentation of Detailed EVENITY ARCH Study Results and FRAME Extension Final Analysis10-Year Data From Long-Term Prolia FREEDOM Study
(September 08, 2017)
[ServletException in:/common/layout/us_view_template.jsp] null'